One recent study in patients with psoriasis and psoriatic arthritis found that overweight individuals who combined a GLP-1 agonist with an anti-IL-17 medication experienced both weight loss and improved disease control compared to those using immunosuppressive therapy alone
But Azagury said thats not a reason to shy away from the medications
Understanding semaglutide Semaglutide is a medication that has gained significant attention for its efficacy in managing weight loss
More recently, dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, like tirzepatide, have emerged as a novel class that combines the actions of both incretin hormones
Originally from Chicago, Sabrina Guillen Fabi, MD, is a globally recognized leader in cosmetic dermatology
Their administration necessitates a healthcare providers guidance to achieve the desired outcomes safely